164 related articles for article (PubMed ID: 22764024)
1. How much do PPIs contribute to C. difficile infections?
Leontiadis GI; Miller MA; Howden CW
Am J Gastroenterol; 2012 Jul; 107(7):1020-1. PubMed ID: 22764024
[TBL] [Abstract][Full Text] [Related]
2. Does confounding explain the association between PPIs and Clostridium difficile-related diarrhea?
Freedberg DE; Abrams JA
Am J Gastroenterol; 2013 Feb; 108(2):278-9. PubMed ID: 23381076
[No Abstract] [Full Text] [Related]
3. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.
Kwok CS; Arthur AK; Anibueze CI; Singh S; Cavallazzi R; Loke YK
Am J Gastroenterol; 2012 Jul; 107(7):1011-9. PubMed ID: 22525304
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor use may be associated with an increased risk of Clostridium difficile infection.
Stevens V; van Wijngaarden E
Evid Based Med; 2013 Oct; 18(5):193-4. PubMed ID: 23220471
[No Abstract] [Full Text] [Related]
5. Risk of Clostridium difficile infection with acid-suppressive therapy; pitfalls in accurate estimation.
Chandra S; Agarwal D; Surana A
Am J Gastroenterol; 2013 Feb; 108(2):277-8. PubMed ID: 23381074
[No Abstract] [Full Text] [Related]
6. Response to Chandra et al., and Freedberg and Abrams.
Loke YK; Kwok CS
Am J Gastroenterol; 2013 Feb; 108(2):279-80. PubMed ID: 23381077
[No Abstract] [Full Text] [Related]
7. Association of Gastric Acid Suppression With Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis.
Tariq R; Singh S; Gupta A; Pardi DS; Khanna S
JAMA Intern Med; 2017 Jun; 177(6):784-791. PubMed ID: 28346595
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitors and risk of Clostridium difficile infection: association or causation?
Villafuerte-Gálvez JA; Kelly CP
Curr Opin Gastroenterol; 2018 Jan; 34(1):11-18. PubMed ID: 29095766
[TBL] [Abstract][Full Text] [Related]
9. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events.
MacLaren R; Kassel LE; Kiser TH; Fish DN
Expert Opin Drug Saf; 2015 Feb; 14(2):269-80. PubMed ID: 25423448
[TBL] [Abstract][Full Text] [Related]
11. Proton-Pump Inhibitor Exposure Aggravates Clostridium difficile-Associated Colitis: Evidence From a Mouse Model.
Hung YP; Ko WC; Chou PH; Chen YH; Lin HJ; Liu YH; Tsai HW; Lee JC; Tsai PJ
J Infect Dis; 2015 Aug; 212(4):654-63. PubMed ID: 25805751
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection.
Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A
Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577
[TBL] [Abstract][Full Text] [Related]
13. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure.
Stevens V; Dumyati G; Brown J; Wijngaarden E
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1035-42. PubMed ID: 21833992
[TBL] [Abstract][Full Text] [Related]
14. Does stress ulcer prophylaxis explain the association between clostridium difficile-associated disease and mechanical ventilation?
Porath AD
Chest; 2010 Apr; 137(4):1001; author reply 1001-2. PubMed ID: 20371539
[No Abstract] [Full Text] [Related]
15. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
16. Proton pump inhibitors: Clostridium difficile infections.
Prescrire Int; 2013 Oct; 22(142):239-40. PubMed ID: 24298587
[TBL] [Abstract][Full Text] [Related]
17. Does PPI therapy predispose to Clostridium difficile infection?
Pant C; Madonia P; Minocha A
Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):555-7. PubMed ID: 19713988
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
Gordon D; Young LR; Reddy S; Bergman C; Young JD
J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
[TBL] [Abstract][Full Text] [Related]
19. Gastric acid-suppressive agents and risk of Clostridium difficile-associated disease.
Leffler D; Cloud JW; Kelly CP
JAMA; 2006 Jun; 295(22):2599-600; author reply 2600-1. PubMed ID: 16772617
[No Abstract] [Full Text] [Related]
20. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
Kim YG; Graham DY; Jang BI
J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
